Stern Lawrence D 4
4 · Talecris Biotherapeutics Holdings Corp. · Filed Apr 4, 2011
Insider Transaction Report
Form 4
Stern Lawrence D
DirectorChairman & CEO
Transactions
- Tax Payment
Common Stock
2011-03-31$26.80/sh−82,067$2,199,396→ 149,899 total
Holdings
- 970,136(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Includes restricted share units representing the right to receive 45,366 shares of the Issuer's common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting person, dated as of September 30, 2009.